Category: News Release

Updates and key announcements from Paradigm Clinical Research, including company news, site openings, leadership updates, and organizational milestones.

Jennifer Hall Joins Paradigm Clinical Research as Chief Financial Officer

JHall

January 12, 2026 Paradigm Clinical Research proudly welcomes Jennifer Hall as chief financial officer. Get in touch to learn more about partnering with Paradigm Clinical Research Contact Us SAN DIEGO, Calif. — Paradigm Clinical Research today announced that Jennifer Hall has joined the company as chief financial officer. She brings nearly 30 years of healthcare and life sciences financial leadership and extensive experience scaling global clinical services, healthcare operations, and technology-enabled businesses. As CFO, she will oversee financial management and strategy to drive profitable growth and continued investment in patient-centered clinical research that advances medicine and improves patient outcomes. In partnership with executive leadership and the board, she will provide leadership support across corporate strategy, IT, human resources and legal matters. A seasoned financial executive, Hall is recognized for building scalable infrastructures, driving strategic growth, and delivering measurable results across healthcare services and healthcare technology organizations. Her collaborative, people-centered leadership has produced high-performing teams, achieved substantial revenue and EBITDA growth, and transformed underperforming operations into market leaders. She also brings deep expertise in mergers and acquisitions, financial planning and analysis, and operational performance improvement. “Jennifer is a thoughtful, experienced leader who aligns financial infrastructure with the needs of patients, sites, and sponsors,” said Kurt Mussina, CEO of Paradigm Clinical Research. “Her expertise in finance strategy, operations, and technology complements our growth, enhancing multisite clinical trial execution and maximizing the impact we deliver to the communities we serve.” Most recently, Hall served as CFO of WellStreet Urgent Care, where she provided strategic, financial, technology and legal leadership for a high-growth, multisite provider that owns, operates, and develops urgent care centers and strategies for large health systems. She developed leadership teams to support rapid expansion and create a scalable, technology-enabled infrastructure that enhanced patient-focused operations. She previously held CFO roles at Nox Health, Revint Solutions (now R1 RCM), and PT Solutions Physical Therapy, as well as senior finance positions with UnitedHealthcare and Akzo Nobel. Hall holds a master’s degree in biomedical engineering and an MBA in finance and accounting from Vanderbilt University, as well as a bachelor’s degree in biomedical engineering from the University of Tennessee, Knoxville. About Paradigm Clinical ResearchParadigm Clinical Research is a long-standing, multi-location, multispecialty clinical research site business with purpose-built research sites in California, Colorado and Idaho. The company operates wholly owned sites that support Phase I-IV clinical trials and provides sponsors with access to diverse, often underrepresented patient populations and investigators. Paradigm’s mission is to enrich lives by offering opportunities to advance the human condition through participation in brilliantly conducted clinical trials. Share: Back to All News

Paradigm Clinical Research to Exhibit at DIA 2025 in Washington, DC

DIA

Schedule a meeting with Paradigm’s clinical research experts and discover how our dedicated team delivers tailored patient recruitment, enrollment, and retention solutions to support the success of your studies. Together, we can advance clinical research and make a lasting impact on patient care. Because making a difference in the lives of patients matters more than ever.

Paradigm Clinical Helps Launch Trade Group to Advance Trials

Multisite-AMRC

Paradigm Clinical Research is proud to co-found the Association of Multisite Research Corporations (AMRC)— a transformative initiative for the clinical trial industry.  January 23, 2025 – Paradigm Clinical Research is proud to announce the launch of the Association of Multisite Research Corporations (AMRC), a transformative initiative for the clinical trial industry. Kurt Mussina, CEO of Paradigm Clinical Research, is a co-founder, highlighting our commitment to advancing the adoption of multisite clinical research corporations (MCRCs) to address long-standing challenges in clinical research. The AMRC brings together 14 industry-leading multisite organizations to establish standardized practices and foster collaboration. This trade association aims to enhance trial execution, improve patient recruitment, and streamline regulatory compliance, ultimately delivering better outcomes for patients and sponsors. Paradigm Clinical Research is honored to be founding members of AMRC in reshaping the clinical research landscape. Together, we are building a more efficient, inclusive, and impactful future for medical innovation. Learn more about the AMRC and register for the upcoming webinar to hear from industry leaders about the future of clinical trials through innovation and collaboration.      

Paradigm Clinical Opens Modesto Site to Expand Trial Access in CA

Paradigm Clinical Research announces the opening of its newest clinical research site in Modesto, California. This expansion aligns with our mission to serve communities historically underrepresented in clinical trials.  The Modesto clinic represents another example of Paradigm Clinical Research’s operating playbook and de novo expansion strategy.  Modesto represents a strategic addition to our footprint, aiming to provide access to clinical trials across the Central Valley region. Our decision to establish a presence in Modesto was driven by the area’s demographic diversity and profound lack of any other professionally managed clinical trial businesses. Our goal in Modesto is to create a robust clinical research ecosystem that supports both study sponsors and the local community. The expansion in Modesto complements Paradigm Clinical Research’s long standing clinic further north in Redding, CA and the company’s strategic interests in the intermediate markets including Sacramento and beyond. This development follows our successful clinic openings in Boise, Idaho, and our flagship site in San Diego. It underscores our mission to provide opportunities to advance the human condition through participation in clinical research.

Paradigm Clinical Celebrates 15 Years with New San Diego Clinic

Paradigm Clinical Research, a leading clinical research site business, announced the opening of its flagship clinic in San Diego, California coinciding with the celebration of the company’s 15th anniversary. This is a significant milestone in the company’s growth strategy, positioning its flagship site to better serve the evolving needs of patients and the clinical research community. “The opening of our flagship clinic solidifies Paradigm Clinical Research’s position at the forefront of the multi-location and multi-specialty clinical research site market,” said Kurt Mussina, CEO of Paradigm Clinical Research. “Our operating model is ‘one site offering many locations and investigators,’ meaning all our clinics and staff function under a single, harmonized set of operating standards and principles. This positions us well to deliver industry-leading value to all stakeholders, especially patients, as evidenced by our exceptional patient Net Promoter Score® of 96. The opening of our San Diego clinic not only aligns with a decade and a half of success, but also validates our unique operating and growth strategies.” “We are proud of the success the entire Paradigm Clinical Research team has achieved, including the opening of the company’s flagship clinic,” said Aleem Choudhry, Managing Partner at Crane Street Capital. “This highlights the strength of the team’s managerial and operational expertise, providing the company with an even greater ability to meet the needs of clinical trial sponsors on so many different levels.” Paradigm Clinical Research celebrates its 15th anniversary this year, marking a decade and a half of success supporting industry sponsored clinical trials. The company remains committed to fostering diversity and inclusion and boasts access to a distinguished team of principal investigators across several therapeutic areas and specialties. For more information about Paradigm Clinical Research and its services, please visit paradigm-research.com. About Paradigm Clinical Research Paradigm Clinical Research is a long-standing clinical research site business with locations in California, Colorado, and Idaho. The company operates wholly owned sites that support Phase I-IV clinical trials and provides sponsors with access to diverse and often under-represented patient populations and investigators. Paradigm’s mission is to enrich lives by offering opportunities to advance the human condition through participation in expertly conducted clinical trials. To learn more, please visit paradigm-research.com. About Crane Street Capital Group Crane Street Capital Group specializes in micro growth buyouts in a few selected fragmented industries with untapped white space potential for growth. Its investments target companies that not only have outsized growth potential within their industries but also have the ability to make tremendously positive impacts within the communities in which they operate. Crane Street maintains a concentrated portfolio, deploys capital on an independent basis when outstanding opportunities are available and implements a patient approach in value creation over typically 5+-year holding periods. Currently, there are seven companies in the portfolio, four of which are in education services and three of which are in healthcare services.